Hemorheology, plasma protein composition and von Willebrand Factor in type I diabetic nephropathy

Clinical Nephrology

Volumn 46, Issue 4, 1996, Pages 230-236

  Zimmermann, J ^a,b   Schramm, L ^a   Wanner, C ^a   Mulzer, E ^a   Henrich, H A ^a   Langer, R ^a   Heidbreder, E ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Blood viscosity; Diabetic nephropathy; Erythrocyte aggregation; Eythrocyte deformability; Fibrinogen; Hemorheology; Plasma viscosity; Von Willebrand Factor

Indexed keywords

ALPHA 2 MACROGLOBULIN; FIBRINOGEN; HAPTOGLOBIN; PLASMA PROTEIN; SERUM ALBUMIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD FLOW; BLOOD RHEOLOGY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENDOTHELIUM INJURY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FEMALE; FIBRINOGEN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; PLASMA VISCOSITY; PROTEIN ANALYSIS; PROTEINURIA;

ADULT; ALBUMINURIA; BLOOD PROTEINS; BLOOD VISCOSITY; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; ENDOTHELIUM, VASCULAR; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FEMALE; HEMORHEOLOGY; HUMANS; MALE; VON WILLEBRAND FACTOR;

EID: 0029828408     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bareford D, Lucas GS, Stone PC, Caldwell NM, McGonigle K, Stuart J 1986 Erythrocyte deformability in chronic renal failure. Clin Hemorheol 6: 501-510
2. Boneu B, Abbal M, Plante J, Bierne R 1975 Factor-VIII complex and endothelial cell damage. Lancet i: 1430
3. Borch-Johnson K, Andersen PK, Deckert T 1985 The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590-596
4. Borch-Johnson K, Kreiner S 1987 Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J 294: 1651-1654
5. Ceriello A 1993 Coagulation activation in diabetes mellitus: the role of hyperglycemia and therapeutic prospects. Diabetologia 36: 1119-1125
6. Chmiel H, Anadere I, Walitza E 1990 The determination of blood viscoelasticity in clinical hemorheology, Biorheol 25: 883-894
7. Deckert T, Feldt-Rasmussen B, Borch-Johnson K, Jensen T, Kofoed-Enevoldsen A 1989 Albuminuria reflects widespread vascular damage, the Steno hypothesis. Diabetologia 32: 219-226
8. Donner M, Mills P, Stoltz JF 1989 Influence of plasma proteins on erythrocyte aggregation. Clin Hemorheol 9: 715-721
9. Ernst E 1994 Fibrinogen: its emerging role as a cardiovascular risk factor. Angiology 45: 87-93
10. Ernst E, Resch KL 1993 Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Int Med 118: 956-936
11. Gordge MP, Faint RW, Rylance PB, Neild GH 1988 Abnormal blood rheology in progressive renal failure: a factor in non-immune glomerular injury? Nephrol Dial Transpl 3: 257-262
12. Gordge MP, Patel A, Faint RW, Rylance PB, Neild GH 1990 Blood hyperviscosity and its relationship to progressive renal failure in patients with diabetic nephropathy. Diabetic Med 7: 880-886
13. Guerrero-Romero F, Rodriguez-Moran M, Paniagua-Sierra JR, Garcia-Bulnes G, Salas-Ramirez M, Amato D 1995 Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients. Clin Nephrol 43: 116-121
14. Heinrich J, Schulte H, Balleisen L, Assmann G, van de Loo J 1991 Predictive value of haemostatic variables in the PROCAM-study. Thromb Haemostasis 65: 815
15. Jay RH, Jones SL, Hill CE, Richmond W, Viberti GC, Rampling MW, Betteridge DJ 1991 Blood rheology and cardiovascular risk factors in type 1 diabetes: relationship with microalbuminuria. Diabetic Med 8: 662-667
16. Jensen T, Stender S, Deckert T 1988 Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 31: 142-145
17. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T 1989 Features of endothelial dysfunction in early diabetic nephropathy. Lancet ii: 461-464
18. Jensen JS 1995 Renal and systemic transvascular albumin leakage in severe atherosclerosis. Arterioscler Thromb Vase Biol 15: 1324-1329
19. Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, Viberti GC 1989 Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. Br Med J 298: 487-190
20. Juhan I, Buonocore M, Jouve R, Vague P, Moulin JP, Violettes B 1982 Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro. Lancet i: 535-537
21. Kannel WB, Wolf PA, Castelli WP et al. 1987 Fibrinogen and risk of cardiovascular disease. JAMA 258; 1183-1186
22. Kiesewetter H, Radtke H, Schneider R, Mussler K, Scheffler A, Schmid-Schönbein H 1982 Mini erythrocyte aggregometer: A new apparatus for rapid quantification of the extent of erythrocyte aggregation. Biomediz Tech 27: 209-211
23. Kofoed-Enevoldsen A, Jensen T, Borch-Johnson K, Deckert T 1987 Incidence of retinopathy in type 1 (insulin-dependent) diabetes: Association with clinical nephropathy. J Diabetic Comp 3: 96-99
24. Lowe GDO, Fowkes FGR, Dawes J, Donnan PT, Lennie SE, Housley E 1993 Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 87: 1915-1920
25. Meade TW, North WRS, Chakrabarti K et al. 1980 Haemostatic function and cardiovascular death: Early results of a prospective study. Lancet i: 1050-1053
26. Myroup B, Rossing P, Jensen T, Gram J, Kluft C, Jespersen J 1995 Procoagulant activity and intimal dysfunction in IDDM. Diabetologia 38: 73-78
27. Othmane A, Bitbol M, Snabre P, Mills P, Grimaldi A, Bosquet F 1989 Red-cell aggregation in insulin-dependent diabetes. Clin Hemorheol 9: 281-295
28. Silveira AMV, Sjöboerg S, Blombäck M, Ostman J 1992 Von Willebrand Factor antigen in plasma and urine in patients with type 1 (insulin-dependent) diabetes mellitus with and without nephropathy. J Diab Comp 6, 2: 89-95
29. Skalak R, Chien S 1981 Capillary flow: history, experiments and theory. Biorheology 18: 207-330
30. Solerte SB, Fioravanti M 1987 Hemodynamic alterations in long-term insulin-dependent diabetic patients with overt nephropathy: role of blood hyperviscosity and plasma protein changes. Clin Nephrol 28: 138-143
31. Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Danker AJM, Den Ottolander GJH 1992 Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340: 319-322
32. Thompson SG, Kienast JK, Pyke SDM, Haverkate F, van de Loo JCW For the european concerted action on thrombosis and disabilities angina pectoris study group 1995 hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 332: 635-641
33. Watts GF, Naumova R, Slavin BM, Morris RW, Houlston R, Kubal C, Shaw KM 1989 Serum lipids and lipoproteins in insulin-dependent diabetic patients with persistent microalbuminuria. Diab Med 6: 25-30
34. Winocour PH, Durington PN, Ishola M, Anderson DC, Cohen H 1987 Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. Br Med J 294: 1648-1651
35. Young MJ, Gennett J, Liderth SA, Veves A, Boulton AJM, Douglas JT 1996 Rheological and microvascular parameters in diabetic peripheral neuropathy. Clinical Science 90: 183-187
36. Zander E, Schulz B, Heinke P, Grimmberger E, Zander G, Gottschling HD 1989 Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic nephropathy. Diabetes Care 12: 159-164